LinkedIn Profile

Access Merrimack Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
nasdaq:mack 26431 Aug 13th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 13th, 2021 10:34AM Aug 13th, 2021 10:34AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 12th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 12th, 2021 09:21AM Aug 12th, 2021 09:21AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 11th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 10th, 2021 11:01PM Aug 10th, 2021 11:01PM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 10th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 10th, 2021 10:30AM Aug 10th, 2021 10:30AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 9th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 9th, 2021 09:25AM Aug 9th, 2021 09:25AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 8th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 8th, 2021 06:19PM Aug 8th, 2021 06:19PM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 7th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 6th, 2021 10:55PM Aug 7th, 2021 05:11PM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 6th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 6th, 2021 09:31AM Aug 6th, 2021 09:31AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 5th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 5th, 2021 12:33AM Aug 5th, 2021 12:30PM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology
nasdaq:mack 26431 Aug 4th, 2021 12:00AM Merrimack 8.4K 68.00 Open Biotechnology Aug 4th, 2021 09:21AM Aug 4th, 2021 09:21AM Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs, including four clinical studies in distinct indications and six candidates in preclinical development, fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to ensure optimal patient outcomes. For more, please visit Merrimack's website at www.merrimack.com or connect on Twitter at @MerrimackPharma. Open Oncology, Network Biology Open One Kendall Square Cambridge Massachusetts US 02139 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.